Maintain long positions in Bitcoin (BTC) and Ethereum (ETH) as core macroeconomic hedges following their technical breakouts above their 200-day moving averages, using MicroStrategy (MSTR) for amplified stock-based upside. Buy Marvell Technology (MRVL) as a top-conviction AI hardware play offering projected 3x to 4x multi-year upside as custom silicon and cloud networking demand expands. Accumulate Eli Lilly (LLY) as a core growth stock over a five-year horizon, backed by robust obesity treatment cash flows and AI-powered drug development that could expand industry valuation multiples from 12x–15x toward 20x–25x. Overweight Silver Miners (SIL) ahead of physical Silver (SLV) as an undervalued, low-multiple hedge against fiat currency inflation. Take tactical positions in high-performance crypto infrastructure operators such as Bitdeer (BTDR), Riot Platforms (RIOT), Hut 8 (HUT), and Iris Energy (IREN) to capture combined exposure to digital assets and AI-driven data center demand.

Bitcoin (BTC)

• Bitcoin is viewed as the purest AI trade because it serves as a non-disruptable store of value and digital monetary rail in an economy increasingly driven by autonomous AI agents.
• The token recently broke decisively back above its 200-day moving average with a massive weekly move (~22%), signaling a major technical regime shift from quiet accumulation to an adoption breakout.
• The asset acts as a hedge against "time risk" and terminal value compression in public equities, as well as against fiat currency debasement driven by large sovereign debt and deficit refinancing.
• Macro and political tailwinds are aligning, including a pro-crypto administration push (e.g., the Clarity Act) and dovish Treasury liquidity management.

Takeaways

• Treat BTC as a core macroeconomic hedge against equity growth uncertainty and sovereign monetary debasement.
• Maintain a bullish outlook as long as price remains above its 200-day moving average.

Ethereum (ETH)

• Ethereum has also turned upward and cleared its 200-day moving average, confirming broader market participation across crypto assets.
• As the underlying smart-contract and settlement ecosystem gains institutional and agentic adoption, crypto beta is expected to lead the next phase of the cycle.

Takeaways

• Exposure to ETH offers high-beta potential that could outperform Bitcoin during this phase of ecosystem expansion and digital rail infrastructure build-out.

Silver & Silver Miners (SLV / SIL)

• Capital was rotated out of crowded AI infrastructure hardware into Silver (SLV) and Silver Miners (SIL) as part of a tangible asset debasement strategy.
• Mining equities (SIL) are positioned as a higher-conviction, larger allocation than physical metal due to being undervalued relative to underlying spot commodity prices.

Takeaways

• Consider precious metals and silver miners as an under-owned, low-multiple hedge against fiat inflation and global currency liquidity shifts.

Eli Lilly (LLY)

• The company is hitting new all-time highs, powered by substantial free cash flow generated from high-demand obesity and metabolic treatments.
• Eli Lilly is aggressively reinvesting this cash into M&A, acquiring stage-two drug candidates, and leveraging proprietary AI data centers to accelerate discovery and development timelines.
• Broader pharmaceutical valuations could see industry-wide multiple re-ratings from 12x–15x up to 20x–25x due to AI-driven discovery efficiencies and margin expansion.

Takeaways

• Position in LLY as a premier growth asset within healthcare that successfully combines massive cash flow with AI-driven operational upside, with long-term potential to become one of the market's largest companies over a five-year horizon.

MicroStrategy (MSTR)

• MicroStrategy has generated roughly 76% annualized returns since late 2022 by functioning as a high-beta corporate proxy for Bitcoin.
• The stock remains positioned to capture amplified upside whenever Bitcoin tests or exceeds previous all-time highs.

Takeaways

• Suitable for equity investors seeking leveraged, liquid corporate balance-sheet exposure to Bitcoin upside without directly holding digital assets.

NVIDIA (NVDA)

• Earnings continue to grow at high rates, maintaining a PEG ratio below 1, which counters typical "bubble" arguments.
• However, the stock is experiencing multiple compression (its price-to-earnings multiple has contracted down toward 19x), causing it to trade range-bound against the broader market for extended periods.
• Because institutional ownership is heavily crowded across AI infrastructure, outsized alpha generation is becoming harder to achieve relative to earlier stages of the AI hardware cycle.

Takeaways

• While fundamentally strong and likely to outperform the broader S&P 500, manage expectations regarding explosive short-term multiple expansion compared to previous years.

Marvell Technology (MRVL)

• Marvell remains a key conviction holding within the AI semiconductor and custom compute space.
• The company offers multi-year upside potential (3x to 4x) as custom silicon and networking demands expand across enterprise and cloud deployments.

Takeaways

• Maintain exposure as a high-upside alternative within semiconductor infrastructure that has room for significant catch-up growth over the next few years.

Bitcoin Miners (BTDR / RIOT / HUT / IREN)

• High-profile family offices (such as Stan Druckenmiller's Duquesne) are rotating out of legacy semiconductor hardware like Intel and Micron in favor of Bitcoin mining and high-performance computing infrastructure, including Bitdeer (BTDR), Riot Platforms (RIOT), Hut 8 (HUT), and Iris Energy (IREN).
• These operators provide dual exposure to decentralized network security and scalable energy/data center infrastructure.

Takeaways

• Mining equities offer a tactical way to gain leveraged exposure to crypto adoption while benefiting from enterprise demand for power and compute facilities.